Search Results - "Teale, C.W." :: K.UTB vyhledávací portál

Loading…

Does Personalised Health Care (PHC) in Oncology Require New Approaches to Clinical Development, Regulatory Assessment, and Economic Evaluation?

by Teale, C.W, Satherley, A.W, Maertens, P, Kreyenberg, K, Konieczny, A
Published in Value in health (01.11.2013)

Get full text

Journal Article

Loading…

A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Combined With A Quantitative Analysis of the Multi-Stakeholder Benefits A Sustainable Medicines Market Would Deliver

by Whitehouse, J.T, Teale, C.W, Glover, J.C, Taylor, C, Lino, Mendonca V
Published in Value in health (01.11.2014)

Get full text

Journal Article

Loading…

PHP317 - IDENTIFYING THE CHANGES REQUIRED IN HEALTH TECHNOLOGY ASSESSMENT SYSTEMS IF OUTCOMES ARE TO BE OPTIMIZED IN A DIGITAL WORLD WHERE PERSONALIZED DATA AND PRECISION MEDICINE COLLIDE

by Teale, C.W., Khan, S., Heupel, M.
Published in Value in health (01.10.2018)

Get full text

Journal Article

Loading…

PHP22 - IS THE EUROPEAN BIOSIMILAR MEDICINES MARKET BECOMING UNSUSTAINABLE? AN EXPLORATION OF THE COMBINED IMPACT OF COMPETITION, INTERCHANGEABILITY, PROCUREMENT, AND PRICING

by Teale, C.W., Sogokon, P., Panciera, D.
Published in Value in health (01.10.2018)

Get full text

Journal Article

Loading…

PCP2 - IS DIGITAL TECHNOLOGY BRINGING THE ADOPTERS CLOSER TO THE DECISION-MAKERS: A COMPARATIVE ASSESSMENT ACROSS FIVE EUROPEAN MARKETS

by Khan, S., Teale, C.W., Heupel, M., Czira, A.
Published in Value in health (01.10.2018)

Get full text

Journal Article

Loading…

PCN176 - Does Personalised Health Care (PHC) in Oncology Require New Approaches to Clinical Development, Regulatory Assessment, and Economic Evaluation?

by Teale, C.W., Satherley, A.W., Maertens, P., Kreyenberg, K., Konieczny, A.
Published in Value in health (01.11.2013)

Get full text

Journal Article

Loading…

PHP28 - A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Combined With A Quantitative Analysis of the Multi-Stakeholder Benefits A Sustainable Medicines Market Would Deliver

by Whitehouse, J.T., Teale, C.W., Glover, J.C., Taylor, C., Lino, Mendonca V.
Published in Value in health (01.11.2014)

Get full text

Journal Article

Does Personalised Health Care (PHC) in Oncology Require New Approaches to Clinical Development, Regulatory Assessment, and Economic Evaluation?

A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Combined With A Quantitative Analysis of the Multi-Stakeholder Benefits A Sustainable Medicines Market Would Deliver

PHP317 - IDENTIFYING THE CHANGES REQUIRED IN HEALTH TECHNOLOGY ASSESSMENT SYSTEMS IF OUTCOMES ARE TO BE OPTIMIZED IN A DIGITAL WORLD WHERE PERSONALIZED DATA AND PRECISION MEDICINE COLLIDE

PHP22 - IS THE EUROPEAN BIOSIMILAR MEDICINES MARKET BECOMING UNSUSTAINABLE? AN EXPLORATION OF THE COMBINED IMPACT OF COMPETITION, INTERCHANGEABILITY, PROCUREMENT, AND PRICING

PCP2 - IS DIGITAL TECHNOLOGY BRINGING THE ADOPTERS CLOSER TO THE DECISION-MAKERS: A COMPARATIVE ASSESSMENT ACROSS FIVE EUROPEAN MARKETS

PCN176 - Does Personalised Health Care (PHC) in Oncology Require New Approaches to Clinical Development, Regulatory Assessment, and Economic Evaluation?

PHP28 - A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Combined With A Quantitative Analysis of the Multi-Stakeholder Benefits A Sustainable Medicines Market Would Deliver

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database